Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 30, 2022 | Series A | $11M | 1 | Blue Horizon Equity | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Blue Horizon Equity | Yes | Series A |